Outlook Therapeutics Inc (OTLK)

[thermo]

Launching a product takes some additional investment, so I don't think that will save them. The company will raise funds either through the sale of common stock or through the sale of a royalty, in my view.

1. Common stock. I think this is most likely. They will likely need to add some warrants to the mix.

2. Royalty. These take a portion of revenue until the investor receives some multiple of the initial investment. The more risk, the higher the multiple. I would guess 3x - 4x in this case.